Invention Grant
- Patent Title: Conjugates of tumor necrosis factor inhibitors to functionalized polymers
-
Application No.: US15850062Application Date: 2017-12-21
-
Publication No.: US10207007B2Publication Date: 2019-02-19
- Inventor: Marek Kwiatkowski
- Applicant: QuiaPEG Pharmaceuticals AB
- Applicant Address: SE Stockholm
- Assignee: QuiaPEG Pharmaceuticals AB
- Current Assignee: QuiaPEG Pharmaceuticals AB
- Current Assignee Address: SE Stockholm
- Agency: Fish & Richardson P.C.
- Main IPC: A61K47/60
- IPC: A61K47/60 ; A61K39/395 ; C07K1/107 ; C07K14/62 ; A61K47/68 ; A61K38/47 ; C07K14/705 ; C07K16/00 ; C07K16/42 ; C07K19/00 ; C12N9/36 ; A61K38/36 ; A61K38/18 ; A61K38/28 ; C12N9/96 ; A61K38/37 ; A61K38/48 ; A61K38/17 ; A61K39/00
Abstract:
This document relates to conjugates of TNF inhibitors or derivatives thereof and functionalized (e.g., mono- or bi-functional) polymers (e.g., polyethylene glycol and related polymers) as well as methods and materials for making and using such conjugates.
Public/Granted literature
- US20180369402A1 CONJUGATES OF TUMOR NECROSIS FACTOR INHIBITORS TO FUNCTIONALIZED POLYMERS Public/Granted day:2018-12-27
Information query
IPC分类:
